Canopy Growth Introduces First & Free - A Line of Branded Hemp-Derived CBD Products to the U.S. Market Canopy Growth's first line of CBD products are available for purchase through e-commerce platform available at www.fi

Canopy Growth Introduces First & Free

- A Line of Branded Hemp-Derived CBD Products to the U.S. Market

Canopy Growth's first

line of CBD products are available for purchase through e-commerce platform available at www.firstandfree.com

DENVER, Dec. 12, 2019 /CNW/ - Canopy Growth

Corporation, USA, LLC (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") today announced the launch

of First & Free - a hemp-derived CBD product line offered in a variety of formats, including softgels, oil drops

and creams. The products will be available for purchase on the company's first e-commerce site: www.firstandfree.com.

Perfected through state-of-the-art technology

and rigorous testing, First & Free products are created by extracting and isolating derivatives from the hemp plant

to produce pure and consistent CBD formulations that are packaged in easy-to-use formats.

"First & Free marks a new way

for US consumers to purchase quality CBD products from a trusted source," said Rade Kovacevic, President, Canopy Growth. "Through

state-of-the art extraction methods, strict quality control measures, and scientific research, we are delivering a best-in-class

product to the market."

At launch, the First & Free brand

will offer the following hemp-derived CBD products:

First & Free Oil Drops

Unflavored 25 mg per mL (750 mg per 30 mL bottle)

Peppermint flavor 25 mg per mL (750 mg per 30 mL bottle)

First & Free Softgels

250 mg CBD carton (10 softgels)

750 mg CBD bottle (30 softgels)

1500 mg CBD bottle (30 softgels)

First & Free Creams*

2500 mg Everyday Cream (CBD Only)

2500 mg Motion Cream (CBD + Arnica)

2500 mg Revitalize Cream (CBD + Capsaicin)

Canopy Growth is committed to selling only

high-quality, tested and reliable products, and ensuring it makes no claims unless clinically validated. This means selling First

& Free products only in states where permissible under state law in order to ensure compliance with state consumer protection

mandates and following the most stringent state laws regarding sale of CBD. The Company is also abiding by existing FDA regulations

for manufacturing, labeling and marketing dietary supplements.

For more information, please visit https://www.firstandfree.com/

Here's to Future (United States made, First

* Creams coming soon

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct

brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's

subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven

by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has operations in over a dozen countries across five continents.

Canopy Growth's medical division, Spectrum

Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the

public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development.

Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as

single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across

Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large

and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto

Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through

leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including

cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation

Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet

of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com

Notice Regarding Forward Looking Statements

This news release contains "forward-looking statements" within the meaning of the United States Private Securities

Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities

legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans",

"expects" or "does not expect", "is expected", "estimates", "intends", "anticipates"

or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions,

events or results "may", "could", "would", "might" or "will" be taken, occur

or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which

may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from

any future results, performance or achievements expressed or implied by the forward-looking statements or information contained

in this news release. Examples of such statements include statements with respect to future product format offerings. Risks, uncertainties

and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities

to differ materially from those expressed or implied by such forward-looking information, including the Company's ability to establish

and maintain CBD product availability in the US, and such risks contained in the Company's annual information form dated June 25,

2019 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. Although

the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements

in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that

such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements included

in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly

update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise

unless required by applicable securities laws.

First & Free CBD Softgels (CNW Group/Canopy

First & Free CBD Oil (CNW Group/Canopy

View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-introduces-first--free---a-line-of-branded-hemp-derived-cbd-products-to-the-us-market-300973966.html

SOURCE Canopy Growth Corporation

View original content to download multimedia:

For further information: Media Contact: Caitlin O'Hara, Corporate

Communications Manager, Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Contact: Tyler Burns, Vice President, Investor Relations,

Tyler.Burns@canopygrowth.com, 855-558-9333 ext. 122

CO: Canopy Growth Corporation

CNW 07:00e 12-DEC-19